Drug Development Pharma - January 31, 2013
The status of orphan drugs
Orphan drugs are a classification of medicines for rare diseases. The market for those medicines is relatively small due to the low number of patients. Since development of pharmaceuticals is expensive, special incentives have been created to encourage pharma and biotech companies to conduct research. As a result a special orphan status was developed in […]
